Speaker illustration

Professor Andrew Sharp

University Hospital of Wales, Cardiff (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Professor Sharp qualified from Edinburgh Medical School in 1998. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the Milan-Imperial Interventional Cardiology fellowship under the tutelage of Professor Antonio Colombo. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, catheter-directed treatments for pulmonary embolism, intracoronary imaging and coronary physiology. He is also a TAVI operator and runs the Cardiff TEER programme.

New treatment option for acute Pulmonary Embolism patients: Percutaneous pulmonary embolectomy with a large-bore catheter system - First European Experience

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb